|
|
Exchange: |
New York Stock Exchange |
Security
Type: |
Common |
Shares
Out: |
1,430,000,000 |
Market
Cap: |
108.57(B) |
Last
Volume: |
3,245,815 |
Avg
Vol: |
8,418,111 |
52
Week Range: |
$48.64 - $75.67 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Health Services |
Level
III Sector: |
Medical Instruments & Supplies |
|
Member Indexes:
|
S&P COMPOSITE 1500 |
|
NYSE COMPOSITE |
|
S&P 500 |
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : 297 |
Guru Rank Value : 4.1 |
Guru Occurances : 2 |
|
|
|
|
|
|
|
Company Profile Boston Scientific develops, manufactures and markets medical devices. Co.'s Medical Surgical segment consist of: Endoscopy, which develops and manufactures devices to diagnose and treat a range of gastrointestinal and pulmonary conditions; and Urology and Pelvic Health, which develops and manufactures devices to treat various urological and pelvic conditions. Co.'s Rhythm and Neuro segment includes: Cardiac Rhythm Management, which develops and manufactures implantable devices to treat cardiac abnormalities; and Electrophysiology, which develops and manufactures medical technologies used in the diagnosis and treatment of rate and rhythm disorders of the heart.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
319,019 |
515,670 |
1,014,661 |
2,126,174 |
Total Sell Value |
$23,643,548 |
$35,428,615 |
$61,747,133 |
$111,248,213 |
Total People Sold |
9 |
10 |
11 |
13 |
Total Sell Transactions |
15 |
28 |
45 |
80 |
End Date |
2024-03-07 |
2023-12-05 |
2023-06-06 |
2022-06-06 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Abele John E |
Director |
|
2010-05-26 |
4 |
AS |
$6.10 |
$457,293 |
I/I |
(75,000) |
3,816,949 |
|
- |
|
Nicholas Peter M |
Director |
|
2010-05-25 |
4 |
AS |
$6.00 |
$149,903 |
I/I |
(25,000) |
8,831,021 |
|
- |
|
Abele John E |
Director |
|
2010-05-25 |
4 |
AS |
$6.00 |
$451,288 |
I/I |
(75,000) |
3,891,949 |
|
- |
|
Abele John E |
Director |
|
2010-05-24 |
4 |
AS |
$6.32 |
$474,203 |
I/I |
(75,000) |
3,966,949 |
|
- |
|
Nicholas Peter M |
Director |
|
2010-05-24 |
4 |
AS |
$6.33 |
$158,143 |
I/I |
(25,000) |
8,856,021 |
|
- |
|
Abele John E |
Director |
|
2010-05-21 |
4 |
AS |
$6.29 |
$473,025 |
I/I |
(75,000) |
4,041,949 |
|
- |
|
Nicholas Peter M |
Director |
|
2010-05-21 |
4 |
AS |
$6.34 |
$158,380 |
I/I |
(25,000) |
8,881,021 |
|
- |
|
Nicholas Peter M |
Director |
|
2010-05-20 |
4 |
AS |
$6.45 |
$161,368 |
I/I |
(25,000) |
8,906,021 |
|
- |
|
Abele John E |
Director |
|
2010-05-20 |
4 |
AS |
$6.44 |
$483,598 |
I/I |
(75,000) |
4,116,949 |
|
- |
|
Nicholas Peter M |
Director |
|
2010-05-19 |
4 |
AS |
$6.64 |
$165,925 |
I/I |
(25,000) |
8,931,021 |
|
- |
|
Abele John E |
Director |
|
2010-05-19 |
4 |
AS |
$6.64 |
$497,885 |
I/I |
(75,000) |
4,191,949 |
|
- |
|
Abele John E |
Director |
|
2010-05-18 |
4 |
AS |
$6.67 |
$501,350 |
I/I |
(75,000) |
4,266,949 |
|
- |
|
Nicholas Peter M |
Director |
|
2010-05-18 |
4 |
AS |
$6.71 |
$167,740 |
I/I |
(25,000) |
8,956,021 |
|
- |
|
Nicholas Peter M |
Director |
|
2010-05-17 |
4 |
AS |
$6.69 |
$167,348 |
I/I |
(25,000) |
8,981,021 |
|
- |
|
Abele John E |
Director |
|
2010-05-17 |
4 |
AS |
$6.69 |
$502,008 |
I/I |
(75,000) |
4,341,949 |
|
- |
|
Lance Jean Fitterer |
SVP & Chief Compliance Officer |
|
2010-05-17 |
4 |
AS |
$6.82 |
$20,208 |
D/D |
(2,963) |
51,908 |
|
- |
|
Lance Jean Fitterer |
SVP & Chief Compliance Officer |
|
2010-05-17 |
4 |
OE |
$6.13 |
$18,148 |
D/D |
2,963 |
54,871 |
|
- |
|
Dawkins Keith D |
Sr. VP, Chief Medical OfficerO |
|
2010-05-11 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
36,948 |
|
- |
|
Connors Nelda J |
Director |
|
2010-04-29 |
4 |
B |
$7.00 |
$17,500 |
D/D |
2,500 |
2,500 |
2.39 |
- |
|
Abele John E |
Director |
|
2010-04-28 |
4 |
AS |
$7.00 |
$524,855 |
I/I |
(75,000) |
4,491,949 |
|
- |
|
Nicholas Peter M |
Director |
|
2010-04-28 |
4 |
AS |
$7.00 |
$174,930 |
I/I |
(25,000) |
9,031,021 |
|
- |
|
Nicholas Peter M |
Director |
|
2010-04-27 |
4 |
AS |
$7.15 |
$178,688 |
I/I |
(25,000) |
9,056,021 |
|
- |
|
Abele John E |
Director |
|
2010-04-27 |
4 |
AS |
$7.11 |
$534,288 |
I/I |
(75,000) |
4,566,949 |
|
- |
|
Abele John E |
Director |
|
2010-04-26 |
4 |
AS |
$7.13 |
$534,995 |
I/I |
(75,000) |
4,641,949 |
|
- |
|
Nicholas Peter M |
Director |
|
2010-04-26 |
4 |
AS |
$7.13 |
$178,185 |
I/I |
(25,000) |
9,081,021 |
|
- |
|
1822 Records found
|
|
Page 40 of 73 |
|
|